Regulation of the immune response by TGF-β: From conception to autoimmunity and infection

Cold Spring Harbor Perspectives in Biology

Volumn 9, Issue 6, 2017, Pages

  Sanjabi, Shomyseh ^a,b   Oh, Soyoung A ^c   Li, Ming O ^c  

^a GLADSTONE INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; AUTOIMMUNITY; B LYMPHOCYTE; BACTERIAL INFECTION; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; DENDRITIC CELL; GRANULOCYTE; HOMEOSTASIS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE ACTIVATION; MACROPHAGE; MAST CELL; MONOCYTE; MOUSE; NATURAL KILLER CELL; PARASITOSIS; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; THYMUS;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; B-LYMPHOCYTES; BACTERIAL INFECTIONS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; GRANULOCYTES; HOMEOSTASIS; HUMANS; IMMUNE TOLERANCE; INFLAMMATORY BOWEL DISEASES; ISOANTIGENS; KILLER CELLS, NATURAL; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MACROPHAGES; MAST CELLS; MICE; MONOCYTES; PARASITIC DISEASES; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND; TRANSFORMING GROWTH FACTOR BETA;

EID: 85020189760     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a022236     Document Type: Article

References (373)

1. Acharya M, Mukhopadhyay S, Paidassi H, Jamil T, Chow C, Kissler S, Stuart LM, Hynes RO, Lacy-Hulbert A. 2010. Av Integrin expression by DCs is required for Th17 cell dif-ferentiation and development of experimental autoimmune encephalomyelitis in mice. J Clin Invest 120: 4445-4452.
2. Alam R, Forsythe P, Stafford S, Fukuda Y. 1994. Transforming growth factor β abrogates the effects of hematopoietins on eosinophils and induces their apoptosis. J Exp Med 179: 1041-1045.
3. Alatrakchi N, Graham CS, van der Vliet HJ, Sherman KE, Exley MA, Koziel MJ. 2007. Hepatitis C virus (HCV)-specific CD8þ cells produce transforming growth factor β that can suppress HCV-specific T-cell responses. J Virol 81: 5882-5892.
4. Allen JB, Manthey CL, Hand AR, Ohura K, Ellingsworth L, Wahl SM. 1990. Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor β. J Exp Med 171: 231-247.
5. Amarnath S, Dong L, Li J, Wu Y, Chen W. 2007. Endogenous TGF-β activation by reactive oxygen species is key to Foxp3 induction in TCR-stimulated and HIV-1-infected human CD4þCD252 T cells. Retrovirology 4: 57.
6. Arnold IC, Lee JY, Amieva MR, Roers A, Flavell RA, Sparwasser T, Muller A. 2011. Tolerance rather than immunity protects from Helicobacter pylori-induced gastric preneoplasia. Gastroenterology 140: 199-209.
7. Arruvito L, Sanz M, Banham AH, Fainboim L. 2007. Expansion of CD4þCD25þ and FOXP3þ regulatory T cells during the follicular phase of the menstrual cycle: Implications for human reproduction. J Immunol 178: 2572-2578.
8. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, et al. 2011. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331: 337-341.
9. Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H, Fukuda S, Saito T, Narushima S, Hase K, et al. 2013. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500: 232-236.
10. Balazovich KJ, Fernandez R, Hinkovska-Galcheva V, Su-chard SJ, Boxer LA. 1996. Transforming growth factor-β1 stimulates degranulation and oxidant release by adherent human neutrophils. J Leukoc Biol 60: 772-777.
11. Barral A, Barral-Netto M, Yong EC, Brownell CE, Twardzik DR, Reed SG. 1993. Transforming growth factor β as a virulence mechanism for Leishmania braziliensis. Proc Natl Acad Sci 90: 3442-3446.
12. Barral-Netto M, Barral A, Brownell CE, Skeiky YA, Ellingsworth LR, Twardzik DR, Reed SG. 1992. Transforming growth factor-b in leishmanial infection: A parasite escape mechanism. Science 257: 545-548.
13. Barreto-de-Souza V, Xavier Medeiros T, Machado Motta MC, Bou-Habib DC, Saraiva EM. 2008. HIV-1 infection and HIV-1 Tat protein permit the survival and replication of a non-pathogenic trypanosomatid in macrophages through TGF-β1 production. Microbes Infect 10: 642-649.
14. Basu R, O’Quinn DB, Silberger DJ, Schoeb TR, Fouser L, Ouyang W, Hatton RD, Weaver CT. 2012. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 37: 1061-1075.
15. Battaglia A, Buzzonetti A, Baranello C, Fanelli M, Fossati M, Catzola V, Scambia G, Fattorossi A. 2013. Interleukin-21 (IL-21) synergizes with IL-2 to enhance T-cell receptor-induced human T-cell proliferation and counteracts IL-2/transforming growth factor-b-induced regulatory T-cell development. Immunology 139: 109-120.
16. Bauer T, Zagorska A, Jurkin J, Yasmin N, Koffel R, Richter S, Gesslbauer B, Lemke G, Strobl H. 2012. Identification of Axl as a downstream effector of TGF-β1 during Langer-hans cell differentiation and epidermal homeostasis. J Exp Med 209: 2033-2047.
17. Bauvois B, Rouillard D, Sanceau J, Wietzerbin J. 1992. IFN-g and transforming growth factor-b1 differently regulate fibronectin and laminin receptors of human differentiating monocytic cells. J Immunol 148: 3912-3919.
18. Beal AM, Ramos-Hernandez N, Riling CR, Nowelsky EA, Oliver PM. 2011. TGF-β induces the expression of the adaptor Ndfip1 to silence IL-4 production during iTreg cell differentiation. Nat Immunol 13: 77-85.
19. Becker-Merok A, Eilertsen GO, Nossent JC. 2010. Levels of transforming growth factor-b are low in systemic lupus erythematosus patients with active disease. J Rheumatol 37: 2039-2045.
20. Belghith M, Bluestone JA, Barriot S, Megret J, Bach JF, Cha-tenoud L. 2003. TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med 9: 1202-1208.
21. Benzoubir N, Lejamtel C, Battaglia S, Testoni B, Benassi B, Gondeau C, Perrin-Cocon L, Desterke C, Thiers V, Samuel D, et al. 2013. HCV core-mediated activation of latent TGF-β via thrombospondin drives the crosstalk between hepatocytes and stromal environment. J Hepatol 59: 1160-1168.
22. Bergsbaken T, Bevan MJ. 2015. Proinflammatory microen-vironments within the intestine regulate the differentiation of tissue-resident CD8þ T cells responding to infection. Nat Immunol 16: 406-414.
23. Beswick EJ, Pinchuk IV, Earley RB, Schmitt DA, Reyes VE. 2011. Role of gastric epithelial cell-derived transforming growth factor β in reduced CD4þ T cell proliferation and development of regulatory T cells during Helicobacter pylori infection. Infect Immun 79: 2737-2745.
24. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. 2006. Reciprocal developmen-tal pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
25. Biancheri P, Giuffrida P, Docena GH, MacDonald TT, Corazza GR, Di Sabatino A. 2014. The role of transforming growth factor (TGF)-b in modulating the immune response and fibrogenesis in the gut. Cytokine Growth Factor Rev 25: 45-55.
26. Bissonnette EY, Enciso JA, Befus AD. 1997. TGF-β1 inhibits the release of histamine and tumor necrosis factor-a from mast cells through an autocrine pathway. Am J Respir Cell Mol Biol 16: 275-282.
27. Boettler T, Cheng Y, Ehrhardt K, von Herrath M. 2012. TGF-β blockade does not improve control of an established persistent viral infection. Viral Immunol 25: 232-238.
28. Boirivant M, Pallone F, Di Giacinto C, Fina D, Monteleone I, Marinaro M, Caruso R, Colantoni A, Palmieri G, Sanchez M, et al. 2006. Inhibition of Smad7 with a specific anti-sense oligonucleotide facilitates TGF-β1-mediated sup-pression of colitis. Gastroenterology 131: 1786-1798.
29. Borkowski TA, Letterio JJ, Farr AG, Udey MC. 1996. A role for endogenous transforming growth factor β1 in Langerhans cell biology: The skin of transforming growth factor β1 null mice is devoid of epidermal Langerhans cells. J Exp Med 184: 2417-2422.
30. Borsutzky S, Cazac BB, Roes J, Guzman CA. 2004. TGF-β receptor signaling is critical for mucosal IgA responses. J Immunol 173: 3305-3309.
31. Bouchard C, Fridman WH, Sautes C. 1997. Effect of TGF-β1 on cell cycle regulatory proteins in LPS-stimulated normal mouse B lymphocytes. J Immunol 159: 4155-4164.
32. Brabletz T, Pfeuffer I, Schorr E, Siebelt F, Wirth T, Serfling E. 1993. Transforming growth factor β and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site. Mol Cell Biol 13: 1155-1162.
33. Brandes ME, Mai UE, Ohura K, Wahl SM. 1991. Type I transforming growth factor-b receptors on neutrophils mediate chemotaxis to transforming growth factor-b. J Immunol 147: 1600-1606.
34. Brennan PJ, Brigl M, Brenner MB. 2013. Invariant natural killer T cells: An innate activation scheme linked to diverse effector functions. Nat Rev Immunol 13: 101-117.
35. Brereton CF, Blander JM. 2010. Responding to infection and apoptosis-A task for TH17 cells. Ann NY Acad Sci 1209: 56-67.
36. Broide DH, Wasserman SI, Alvaro-Gracia J, Zvaifler NJ, Firestein GS. 1989. Transforming growth factor-b1 selectively inhibits IL-3-dependent mast cell proliferation without affecting mast cell function or differentiation. J Immunol 143: 1591-1597.
37. Campillo-Gimenez L, Cumont MC, Fay M, Kared H, Mon-ceaux V, Diop O, Muller-Trutwin M, Hurtrel B, Levy Y, Zaunders J, et al. 2010. AIDS progression is associated with the emergence of IL-17-producing cells early after simian immunodeficiency virus infection. J Immunol 184: 984-992.
38. Carlson CM, Turpin EA, Moser LA, O’Brien KB, Cline TD, Jones JC, Tumpey TM, Katz JM, Kelley LA, Gauldie J, et al. 2010. Transforming growth factor-β: Activation by neuraminidase and role in highly pathogenic H5N1 in-fluenza pathogenesis. PLoS Path 6: e1001136.
39. Casey KA, Fraser KA, Schenkel JM, Moran A, Abt MC, Beura LK, Lucas PJ, Artis D, Wherry EJ, Hogquist K, et al. 2012. Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues. J Im-munol 188: 4866-4875.
40. Castriconi R, Cantoni C, Della Chiesa M, Vitale M, Marce-naro E, Conte R, Biassoni R, Bottino C, Moretta L, Moretta A. 2003. Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors: Consequences for the NK-mediated killing of dendritic cells. Proc Natl Acad Sci 100: 4120-4125.
41. Cauley LS, Lefrancois L. 2013. Guarding the perimeter: Protection of the mucosa by tissue-resident memory T cells. Mucosal Immunol 6: 14-23.
42. Cazac BB, Roes J. 2000. TGF-β receptor controls B cell responsiveness and induction of IgA in vivo. Immunity 13: 443-451.
43. Cepek KL, Parker CM, Madara JL, Brenner MB. 1993. In-tegrin aEb7 mediates adhesion of T lymphocytes to epithelial cells. J Immunol 150: 3459-3470.
44. Cerutti A, Chen K, Chorny A. 2011. Immunoglobulin re-sponses at the mucosal interface. Annu Rev Immunol 29: 273-293.
45. Chahroudi A, Bosinger SE, Vanderford TH, Paiardini M, Silvestri G. 2012. Natural SIV hosts: Showing AIDS the door. Science 335: 1188-1193.
46. Chalmin F, Mignot G, Bruchard M, Chevriaux A, Vegran F, Hichami A, Ladoire S, Derangere V, Vincent J, Masson D, et al. 2012. Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression. Immunity 36: 362-373.
47. Chantry D, Turner M, Abney E, Feldmann M. 1989. Modulation of cytokine production by transforming growth factor-β. J Immunol 142: 4295-4300.
48. Chegini N, Zhao Y, Williams RS, Flanders KC. 1994. Human uterine tissue throughout the menstrual cycle expresses transforming growth factor-b1 (TGFβ 1), TGFβ2, TGFβ3, and TGFβ type II receptor messenger ribonucleic acid and protein and contains [125I]TGFβ1-binding sites. Endocrinology 135: 439-449.
49. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. 1994. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 265: 1237-1240.
50. Chen CH, Seguin-Devaux C, Burke NA, Oriss TB, Watkins SC, Clipstone N, Ray A. 2003a. Transforming growth factor β blocks Tec kinase phosphorylation, Ca2þ influx, and NFATc translocation causing inhibition of T cell dif-ferentiation. J Exp Med 197: 1689-1699.
51. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM. 2003b. Conversion of peripheral CD4þCD252 naive T cells to CD4þCD25þ regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 198: 1875-1886.
52. Chen S, Tuttle DL, Oshier JT, Knot HJ, Streit WJ, Goodenow MM, Harrison JK. 2005. Transforming growth factor-β1 increases CXCR4 expression, stromal-derived factor-1a-stimulated signalling and human immunodeficiency vi-rus-1 entry in human monocyte-derived macrophages. Immunology 114: 565-574.
53. Chen ML, Yan BS, Bando Y, Kuchroo VK, Weiner HL. 2008. Latency-associated peptide identifies a novel CD4þCD25þ regulatory T cell subset with TGFβ-mediated function and enhanced suppression of experimental autoimmune en-cephalomyelitis. J Immunol 180: 7327-7337.
54. Cheroutre H, Lambolez F, Mucida D. 2011. The light and dark sides of intestinal intraepithelial lymphocytes. Nat Rev Immunol 11: 445-456.
55. Chikuma S, Suita N, Okazaki IM, Shibayama S, Honjo T. 2012. TRIM28 prevents autoinflammatory T cell development in vivo. Nat Immunol 13: 596-603.
56. Choi KC, Lee YS, Lim S, Choi HK, Lee CH, Lee EK, Hong S, Kim IH, Kim SJ, Park SH. 2006. Smad6 negatively regulates interleukin 1-receptor-Toll-like receptor signaling through direct interaction with the adaptor Pellino-1. Nat Immunol 7: 1057-1065.
57. Chopin M, Seillet C, Chevrier S, Wu L, Wang H, Morse HC III, Belz GT, Nutt SL. 2013. Langerhans cells are generated by two distinct PU.1-dependent transcriptional net-works. J Exp Med 210: 2967-2980.
58. Clark DA, Fernandes J, Banwatt D. 2008. Prevention of spontaneous abortion in the CBA DBA/2 mouse model by intravaginal TGF-β and local recruitment of CD4þ 8þ FOXP3þ cells. Am J Reprod Immunol 59: 525-534.
59. Coffman RL, Lebman DA, Shrader B. 1989. Transforming growth factor β specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J Exp Med 170: 1039-1044.
60. Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, Hall J, Sun CM, Belkaid Y, Powrie F. 2007. A functionally specialized population of mucosal CD103þ DCs induces Foxp3þ regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J Exp Med 204: 1757-1764.
61. Cottrez F, Groux H. 2001. Regulation of TGF-β response during T cell activation is modulated by IL-10. J Immunol 167: 773-778.
62. Crane CA, Han SJ, Barry JJ, Ahn BJ, Lanier LL, Parsa AT. 2010. TGF-β downregulates the activating receptor NKG2D on NK cells and CD8þ T cells in glioma patients. Neuro Oncol 12: 7-13.
63. Crotty S. 2011. Follicular helper CD4 T cells (TFH). Annu Rev Immunol 29: 621-663.
64. Cumont MC, Monceaux V, Viollet L, Lay S, Parker R, Hurtrel B, Estaquier J. 2007. TGF-β in intestinal lymphoid organs contributes to the death of armed effector CD8 T cells and is associated with the absence of virus containment in rhesus macaques infected with the simian immunodeficiency virus. Cell Death Differ 14: 1747-1758.
65. Dai CY, Chuang WL, Lee LP, Pan WC, Huang JF, Hsieh MY, Hou NJ, Lin ZY, Chen SC, Wang LY, et al. 2008. Association between transforming growth factor-b1 polymorphism and virologic characteristics of chronic hepatitis C. Transl Res 152: 151-156.
66. Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W, Sobel RA, Mitsdoerffer M, Strom TB, Elyaman W, Ho IC, et al. 2008. IL-4 inhibits TGF-β-induced Foxp3þ T cells and, together with TGF-β, generates IL-9þ IL-10þ Foxp3-ef-fector T cells. Nat Immunol 9: 1347-1355.
67. Das J, Ren G, Zhang L, Roberts AI, Zhao X, Bothwell AL, Van Kaer L, Shi Y, Das G. 2009. Transforming growth factor β is dispensable for the molecular orchestration of Th17 cell differentiation. J Exp Med 206: 2407-2416.
68. DePaolo RW, Kamdar K, Khakpour S, Sugiura Y, Wang W, Jabri B. 2012. A specific role for TLR1 in protective TH17 immunity during mucosal infection. J Exp Med 209: 1437-1444.
69. De Saint Jean A, Lucht F, Bourlet T, Delezay O. 2014. Trans-forming growth factor β1 up-regulates CD169 (sialoadhesin) expression on monocyte-derived dendritic cells: Role in HIV sexual transmission. AIDS 28: 2375-2380.
70. Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M. 2005. Probiotics ameliorate recurrent Th1-me-diated murine colitis by inducing IL-10 and IL-10-dependent TGF-β-bearing regulatory cells. J Immunol 174: 3237-3246.
71. Dittrich AM, Erbacher A, Specht S, Diesner F, Krokowski M, Avagyan A, Stock P, Ahrens B, Hoffmann WH, Hoerauf A, et al. 2008. Helminth infection with Litomosoides sig-modontis induces regulatory T cells and inhibits allergic sensitization, airway inflammation, and hyperreactivity in a murine asthma model. J Immunol 180: 1792-1799.
72. Doisne JM, Bartholin L, Yan KP, Garcia CN, Duarte N, Le Luduec JB, Vincent D, Cyprian F, Horvat B, Martel S, et al. 2009. iNKT cell development is orchestrated by different branches of TGF-β signaling. J Exp Med 206: 1365-1378.
73. Donatelli SS, Zhou JM, Gilvary DL, Eksioglu EA, Chen X, Cress WD, Haura EB, Schabath MB, Coppola D, Wei S, et al. 2014. TGF-β-inducible microRNA-183 silences tumor-associated natural killer cells. Proc Natl Acad Sci 111: 4203-4208.
74. Donnet-Hughes A, Duc N, Serrant P, Vidal K, Schiffrin EJ. 2000. Bioactive molecules in milk and their role in health and disease: The role of transforming growth factor-β. Immunol Cell Biol 78: 74-79.
75. Dunham RM, Thapa M, Velazquez VM, Elrod EJ, Denning TL, Pulendran B, Grakoui A. 2013. Hepatic stellate cells preferentially induce Foxp3þ regulatory T cells by production of retinoic acid. J Immunol 190: 2009-2016.
76. Edwards JP, Fujii H, Zhou AX, Creemers J, Unutmaz D, Shevach EM. 2013. Regulation of the expression of GARP/latent TGF-β1 complexes on mouse T cells and their role in regulatory T cell and Th17 differentiation. J Immunol 190: 5506-5515.
77. Ehrhardt RO, Strober W, Harriman GR. 1992. Effect of transforming growth factor (TGF)-b1 on IgA isotype expression. TGF-β1 induces a small increase in sIgAþ B cells regardless of the method of B cell activation. J Immunol 148: 3830-3836.
78. El-Asady R, Yuan R, Liu K, Wang D, Gress RE, Lucas PJ, Drachenberg CB, Hadley GA. 2005. TGF-β-dependent CD103 expression by CD8þ T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease. J Exp Med 201: 1647-1657.
79. Elyaman W, Bassil R, Bradshaw EM, Orent W, Lahoud Y, Zhu B, Radtke F, Yagita H, Khoury SJ. 2012. Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells. Immunity 36: 623-634.
80. Eriksson M, Meadows SK, Wira CR, Sentman CL. 2004. Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-β. J Leukocyte Biol 76: 667-675.
81. Eriksson M, Meadows SK, Wira CR, Sentman CL. 2006. Endogenous transforming growth factor-b inhibits toll-like receptor mediated activation of human uterine natural killer cells. Am J Reprod Immunol 56: 321-328.
82. Esplugues E, Huber S, Gagliani N, Hauser AE, Town T, Wan YY, O’Connor W Jr, Rongvaux A, Van Rooijen N, Haberman AM, et al. 2011. Control of TH17 cells occurs in the small intestine. Nature 475: 514-518.
83. Estes JD, Wietgrefe S, Schacker T, Southern P, Beilman G, Reilly C, Milush JM, Lifson JD, Sodora DL, Carlis JV, et al. 2007. Simian immunodeficiency virus-induced lymphatic tissue fibrosis is mediated by transforming growth factor β1-positive regulatory T cells and begins in early infection. J Infect Dis 195: 551-561.
84. Fainaru O, Woolf E, Lotem J, Yarmus M, Brenner O, Gol-denberg D, Negreanu V, Bernstein Y, Levanon D, Jung S, et al. 2004. Runx3 regulates mouse TGF-β-mediated dendritic cell function and its absence results in airway inflammation. EMBO J 23: 969-979.
85. Fan K, Ruan Q, Sensenbrenner L, Chen B. 1992. Transforming growth factor-β1 bifunctionally regulates murine macrophage proliferation. Blood 79: 1679-1685.
86. Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, Neurath MF. 2004. Cutting edge: TGF-β induces a regulatory phenotype in CD4þCD252 T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 172: 5149-5153.
87. Fantini MC, Rizzo A, Fina D, Caruso R, Sarra M, Stolfi C, Becker C, Macdonald TT, Pallone F, Neurath MF, et al. 2009. Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression. Gastroenterology 136: 1308-1316, e1301-e1303.
88. Fava RA, Olsen NJ, Postlethwaite AE, Broadley KN, David-son JM, Nanney LB, Lucas C, Townes AS. 1991. Transforming growth factor β1 (TGF-β1) induced neutrophil recruitment to synovial tissues: Implications for TGF-β-driven synovial inflammation and hyperplasia. J Exp Med 173: 1121-1132.
89. Feagins LA. 2010. Role of transforming growth factor-b in inflammatory bowel disease and colitis-associated colon cancer. Inflamm Bowel Dis 16: 1963-1968.
90. Fina D, Franze E, Rovedatti L, Corazza GR, Biancone L, Sileri PP, Sica G, MacDonald TT, Pallone F, Di Sabatino A, et al. 2011. Interleukin-25 production is differently regulated by TNF-a and TGF-β1 in the human gut. Mucosal im-munol 4: 239-244.
91. Fiocchi C. 2001. TGF-β/Smad signaling defects in inflam-matory bowel disease: Mechanisms and possible novel therapies for chronic inflammation. J Clin Invest 108: 523-526.
92. Fogel-Petrovic M, Long JA, Misso NL, Foster PS, Bhoola KD, Thompson PJ. 2007. Physiological concentrations of transforming growth factor β1 selectively inhibit human dendritic cell function. Int Immunopharmacol 7: 1924-1933.
93. Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T, Lees CW, Balschun T, Lee J, Roberts R, et al. 2010. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat Genet 42: 1118-1125.
94. Fuss IJ, Boirivant M, Lacy B, Strober W. 2002. The interre-lated roles of TGF-β and IL-10 in the regulation of experimental colitis. J Immunol 168: 900-908.
95. Gagliani N, Vesely MC, Iseppon A, Brockmann L, Xu H, Palm NW, de Zoete MR, Licona-Limon P, Paiva RS, Ching T, et al. 2015. TH17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 523: 221-225.
96. Ganeshan K, Bryce PJ. 2012. Regulatory T cells enhance mast cell production of IL-6 via surface-bound TGF-β. J Immunol 188: 594-603.
97. Gebhardt T, Lorentz A, Detmer F, Trautwein C, Bektas H, Manns MP, Bischoff SC. 2005. Growth, phenotype, and function of human intestinal mast cells are tightly regulated by transforming growth factor β1. Gut 54: 928-934.
98. Geissmann F, Prost C, Monnet JP, Dy M, Brousse N, Hermine O. 1998. Transforming growth factor β1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med 187: 961-966.
99. Geissmann F, Revy P, Regnault A, Lepelletier Y, Dy M, Brousse N, Amigorena S, Hermine O, Durandy A. 1999. TGF-β1 prevents the noncognate maturation of human dendritic Langerhans cells. J Immunol 162: 4567-4575.
100. Genestier L, Kasibhatla S, Brunner T, Green DR. 1999. Transforming growth factor β1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc. J Exp Med 189: 231-239.
101. Ghoreschi K, Laurence A, Yang XP, Tato CM, McGeachy MJ, Konkel JE, Ramos HL, Wei L, Davidson TS, Bouladoux N, et al. 2010. Generation of pathogenic TH17 cells in the absence of TGF-β signalling. Nature 467: 967-971.
102. Ginhoux F, Jung S. 2014. Monocytes and macrophages: Developmental pathways and tissue homeostasis. Nat Rev Immunol 14: 392-404.
103. Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schaffer AA, Noyan F, Perro M, Diestelhorst J, Allroth A, Murugan D, et al. 2009. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 361: 2033-2045.
104. Gomez G, Ramirez CD, Rivera J, Patel M, Norozian F, Wright HV, Kashyap MV, Barnstein BO, Fischer-Stenger K, Schwartz LB, et al. 2005. TGF-β1 inhibits mast cell Fc1RI expression. J Immunol 174: 5987-5993.
105. Gorelik L, Flavell RA. 2000. Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12: 171-181.
106. Gorelik L, Fields PE, Flavell RA. 2000. Cutting edge: TGF-β inhibits Th type 2 development through inhibition of GATA-3 expression. J Immunol 165: 4773-4777.
107. Gorelik L, Constant S, Flavell RA. 2002. Mechanism of transforming growth factor β-induced inhibition of T helper type 1 differentiation. J Exp Med 195: 1499-1505.
108. Grainger JR, Smith KA, Hewitson JP, McSorley HJ, Harcus Y, Filbey KJ, Finney CA, Greenwood EJ, Knox DP, Wilson MS, et al. 2010. Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway. J Exp Med 207: 2331-2341.
109. Grewal IS, Grewal KD, Wong FS, Wang H, Picarella DE, Janeway CA Jr, Flavell RA. 2002. Expression of transgene encoded TGF-β in islets prevents autoimmune diabetes in NOD mice by a local mechanism. J Autoimmun 19: 9-22.
110. Gruber BL, Marchese MJ, Kew RR. 1994. Transforming growth factor-b1 mediates mast cell chemotaxis. J Immu-nol 152: 5860-5867.
111. Gu AD, Wang Y, Lin L, Zhang SS, Wan YY. 2012. Requirements of transcription factor Smad-dependent and -independent TGF-β signaling to control discrete T-cell functions. Proc Natl Acad Sci 109: 905-910.
112. Gunnlaugsdottir B, Maggadottir SM, Ludviksson BR. 2005. Anti-CD28-induced co-stimulation and TCR avidity regulates the differential effect of TGF-β1 on CD4þ and CD8þ naive human T-cells. Int Immunol 17: 35-44.
113. Gutcher I, Donkor MK, Ma Q, Rudensky AY, Flavell RA, Li MO. 2011. Autocrine transforming growth factor-b1 promotes in vivo Th17 cell differentiation. Immunity 34: 396-408.
114. Hanai J, Chen LF, Kanno T, Ohtani-Fujita N, Kim WY, Guo WH, Imamura T, Ishidou Y, Fukuchi M, Shi MJ, et al. 1999. Interaction and functional cooperation of PEBP2/ CBF with Smads. Synergistic induction of the immu-noglobulin germline Ca promoter. J Biol Chem 274: 31577-31582.
115. Harrison OJ, Powrie FM. 2013. Regulatory T cells and immune tolerance in the intestine. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a018341.
116. Hawkes JS, Bryan DL, James MJ, Gibson RA. 1999. Cytokines (IL-1b, IL-6, TNF-a, TGF-β1, and TGF-β2) and prostaglandin E2 in human milk during the first three months postpartum. Pediatr Res 46: 194-199.
117. Heath VL, Murphy EE, Crain C, Tomlinson MG, O’Garra A. 2000. TGF-β1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression. Eur J Immunol 30: 2639-2649.
118. Hernandez-Garay M, Mendez-Samperio P. 2003. Transforming growth factor-b decreases survival of Mycobacterium bovis-activated T cells. Arch Med Res 34: 20-25.
119. Honda K, Littman DR. 2012. The microbiome in infectious disease and inflammation. Annu Rev Immunol 30: 759-795.
120. Hong S, Lim S, Li AG, Lee C, Lee YS, Lee EK, Park SH, Wang XJ, Kim SJ. 2007. Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2. Nat Immunol 8: 504-513.
121. Hu R, Oyaizu N, Than S, Kalyanaraman VS, Wang XP, Pahwa S. 1996. HIV-1 gp160 induces transforming growth factor-b production in human PBMC. Clin Im-munol Immunopathol 80: 283-289.
122. Hu Y, Lee YT, Kaech SM, Garvy B, Cauley LS. 2015. Smad4 promotes differentiation of effector and circulating memory CD8 T cells but is dispensable for tissue-resident memory CD8 T cells. J Immunol 194: 2407-2414.
123. Ichiyama K, Sekiya T, Inoue N, Tamiya T, Kashiwagi I, Kimura A, Morita R, Muto G, Shichita T, Takahashi R, et al. 2011. Transcription factor Smad-independent T helper 17 cell induction by transforming-growth factor-β is mediated by suppression of eomesodermin. Immunity 34: 741-754.
124. Ishigame H, Mosaheb MM, Sanjabi S, Flavell RA. 2013a. Truncated form of TGF-βRII, but not its absence, induces memory CD8þ T cell expansion and lymphoprolifer-ative disorder in mice. J Immunol 190: 6340-6350.
125. Ishigame H, Zenewicz LA, Sanjabi S, Licona-Limon P, Nakayama M, Leonard WJ, Flavell RA. 2013b. Excessive Th1 responses due to the absence of TGF-β signaling cause autoimmune diabetes and dysregulated Treg cell homeostasis. Proc Natl Acad Sci 110: 6961-6966.
126. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR. 2006. The orphan nuclear receptor RORgt directs the differentiation program of proinflammatory IL-17þ T helper cells. Cell 126: 1121-1133.
127. Ivanov II, Frutos Rde L, Manel N, Yoshinaga K, Rifkin DB, Sartor RB, Finlay BB, Littman DR. 2008. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4: 337-349.
128. Izcue A, Coombes JL, Powrie F. 2009. Regulatory lympho-cytes and intestinal inflammation. Annu Rev Immunol 27: 313-338.
129. Jarry A, Bossard C, Bou-Hanna C, Masson D, Espaze E, Denis MG, Laboisse CL. 2008. Mucosal IL-10 and TGF-β play crucial roles in preventing LPS-driven, IFN-g-mediated epithelial damage in human colon explants. J Clin Invest 118: 1132-1142.
130. Jarry A, Bossard C, Sarrabayrouse G, Mosnier JF, Laboisse CL. 2011. Loss of interleukin-10 or transforming growth factor β signaling in the human colon initiates a T-helper 1 response via distinct pathways. Gastroenterology 141: 1887-1896, e1-e2.
131. Jelicic K, Cimbro R, Nawaz F, Huang da W, Zheng X, Yang J, Lempicki RA, Pascuccio M, Van Ryk D, Schwing C, et al. 2013. The HIV-1 envelope protein gp120 impairs B cell proliferation by inducing TGF-β1 production and FcRL4 expression. Nat Immunol 14: 1256-1265.
132. Johns LD, Flanders KC, Ranges GE, Sriram S. 1991. Success-ful treatment of experimental allergic encephalomyelitis with transforming growth factor-β1. J Immunol 147: 1792-1796.
133. Johnson LD, Jameson SC. 2012. TGF-β sensitivity restrains CD8þ T cell homeostatic proliferation by enforcing sensitivity to IL-7 and IL-15. PLoS ONE 7: e42268.
134. Josefowicz SZ, Wilson CB, Rudensky AY. 2009. Cutting edge: TCR stimulation is sufficient for induction of Foxp3 ex-pression in the absence of DNA methyltransferase 1. J Immunol 182: 6648-6652.
135. Josefowicz SZ, Lu LF, Rudensky AY. 2012. Regulatory T cells: Mechanisms of differentiation and function. Annu Rev Immunol 30: 531-564.
136. Kalliomaki M, Ouwehand A, Arvilommi H, Kero P, Isolauri E. 1999. Transforming growth factor-β in breast milk: A potential regulator of atopic disease at an early age. J Allergy Clin Immunol 104: 1251-1257.
137. Kang SS, Bloom SM, Norian LA, Geske MJ, Flavell RA, Stappenbeck TS, Allen PM. 2008. An antibiotic-responsive mouse model of fulminant ulcerative colitis. PLoS Med 5: e41.
138. Kang SG, Park J, Cho JY, Ulrich B, Kim CH. 2011. Comple-mentary roles of retinoic acid and TGF-β1 in coordinated expression of mucosal integrins by T cells. Mucosal Immunol 4: 66-82.
139. Kaplan DH, Li MO, Jenison MC, Shlomchik WD, Flavell RA, Shlomchik MJ. 2007. Autocrine/paracrine TGFβ1 is required for the development of epidermal Langerhans cells. J Exp Med 204: 2545-2552.
140. Karimi-Googheri M, Daneshvar H, Nosratabadi R, Zare-Bidaki M, Hassanshahi G, Ebrahim M, Arababadi MK, Kennedy D. 2014. Important roles played by TGF-β in hepatitis B infection. J Med Virol 86: 102-108.
141. Kashiwagi I, Morita R, Schichita T, Komai K, Saeki K, Mat-sumoto M, Takeda K, Nomura M, Hayashi A, Kanai T, et al. 2015. Smad2 and Smad3 inversely regulate TGF-β autoinduction in Clostridium butyricum-activated dendritic cells. Immunity 43: 65-79.
142. Kee BL, Rivera RR, Murre C. 2001. Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-β. Nat Immunol 2: 242-247.
143. Kehrl JH, Roberts AB, Wakefield LM, Jakowlew S, Sporn MB, Fauci AS. 1986a. Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes. J Immunol 137: 3855-3860.
144. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, Sporn MB, Fauci AS. 1986b. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 163: 1037-1050.
145. Kehrl JH, Thevenin C, Rieckmann P, Fauci AS. 1991. Trans-forming growth factor-β suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA. J Immunol 146: 4016-4023.
146. Kel JM, Girard-Madoux MJ, Reizis B, Clausen BE. 2010. TGF-β is required to maintain the pool of immature Langerhans cells in the epidermis. J Immunol 185: 3248-3255.
147. Khorramdelazad H, Hassanshahi G, Nasiri Ahmadabadi B, Kazemi Arababadi M. 2012. High serum levels of TGF-β in Iranians with chronic HBV infection. Hepat Mon 12: e7581.
148. Kieper WC, Burghardt JT, Surh CD. 2004. A role for TCR affinity in regulating naive T cell homeostasis. J Immunol 172: 40-44.
149. Kim PH, Kagnoff MF. 1990. Transforming growth factor β1 increases IgA isotype switching at the clonal level. J Immunol 145: 3773-3778.
150. Kim MR, Park DW, Lee JH, Choi DS, Hwang KJ, Ryu HS, Min CK. 2005. Progesterone-dependent release of transforming growth factor-β1 from epithelial cells enhances the endometrial decidualization by turning on the Smad signalling in stromal cells. Mol Human Reprod 11: 801-808.
151. King C, Davies J, Mueller R, Lee MS, Krahl T, Yeung B, O’Connor E, Sarvetnick N. 1998. TGF-β1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype. Immunity 8: 601-613.
152. Kitani A, Fuss I, Nakamura K, Kumaki F, Usui T, Strober W. 2003. Transforming growth factor (TGF)-b1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-β1-mediated fibrosis. J Exp Med 198: 1179-1188.
153. Klein J, Ju W, Heyer J, Wittek B, Haneke T, Knaus P, Kucher-lapati R, Bottinger EP, Nitschke L, Kneitz B. 2006. B cell-specific deficiency for Smad2 in vivo leads to defects in TGF-β-directed IgA switching and changes in B cell fate. J Immunol 176: 2389-2396.
154. Kohyama M, Yasogi Y, Nakano N, Ise W, Kaminogawa S, Hozumi N. 2005. Ca2þ signaling down-regulates TGF-β1 gene expression in CD4þ T cells. Biochem Biophys Res Commun 327: 494-499.
155. Konkel JE, Maruyama T, Carpenter AC, Xiong Y, Zamarron BF, Hall BE, Kulkarni AB, Zhang P, Bosselut R, Chen W. 2011. Control of the development of CD8aaþ intestinal intraepithelial lymphocytes by TGF-β. Nat Immunol 12: 312-319.
156. Korn T, Bettelli E, Oukka M, Kuchroo VK. 2009. IL-17 and Th17 Cells. Annu Rev Immunol 27: 485-517.
157. Kornfeld C, Ploquin MJ, Pandrea I, Faye A, Onanga R, Apetrei C, Poaty-Mavoungou V, Rouquet P, Estaquier J, Mor-tara L, et al. 2005. Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest 115: 1082-1091.
158. Kuruvilla AP, Shah R, Hochwald GM, Liggitt HD, Palladino MA, Thorbecke GJ. 1991. Protective effect of transforming growth factor β1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci 88: 2918-2921.
159. Kuwahara M, Yamashita M, Shinoda K, Tofukuji S, Onodera A, Shinnakasu R, Motohashi S, Hosokawa H, Tumes D, Iwamura C, et al. 2012. The transcription factor Sox4 is a downstream target of signaling by the cytokine TGF-β and suppresses TH2 differentiation. Nat Immunol 13: 778-786.
160. Lacy-Hulbert A, Smith AM, Tissire H, Barry M, Crowley D, Bronson RT, Roes JT, Savill JS, Hynes RO. 2007. Ulcerative colitis and autoimmunity induced by loss of myeloid av integrins. Proc Natl Acad Sci 104: 15823-15828.
161. Laouar Y, Sutterwala FS, Gorelik L, Flavell RA. 2005. Transforming growth factor-β controls T helper type 1 cell development through regulation of natural killer cell interferon-g. Nat Immunol 6: 600-607.
162. Lebman DA, Edmiston JS. 1999. The role of TGF-β in growth, differentiation, and maturation of B lymphocytes. Microbes Infect 1: 1297-1304.
163. Lebman DA, Lee FD, Coffman RL. 1990. Mechanism for transforming growth factor β and IL-2 enhancement of IgA expression in lipopolysaccharide-stimulated B cell cultures. J Immunol 144: 952-959.
164. Lee DK, Park SH, Yi Y, Choi SG, Lee C, Parks WT, Cho H, de Caestecker MP, Shaul Y, Roberts AB, et al. 2001. The hepatitis B virus encoded oncoprotein pX amplifies TGF-β family signaling through direct interaction with Smad4: Potential mechanism of hepatitis B virus-induced liver fibrosis. Genes Dev 15: 455-466.
165. Lee JC, Lee KM, Kim DW, Heo DS. 2004. Elevated TGF-β1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients. J Immunol 172: 7335-7340.
166. Lee YS, Kim JH, Kim ST, Kwon JY, Hong S, Kim SJ, Park SH. 2010. Smad7 and Smad6 bind to discrete regions of Pellino-1 via their MH2 domains to mediate TGF-β1-in-duced negative regulation of IL-1R/TLR signaling. Biochem Biophys Res Commun 393: 836-843.
167. Lee YS, Park JS, Kim JH, Jung SM, Lee JY, Kim SJ, Park SH. 2011. Smad6-specific recruitment of Smurf E3 ligases mediates TGF-β1-induced degradation of MyD88 in TLR4 signalling. Nat Commun 2: 460.
168. Lee Y, Awasthi A, Yosef N, Quintana FJ, Xiao S, Peters A, Wu C, Kleinewietfeld M, Kunder S, Hafler DA, et al. 2012. Induction and molecular signature of pathogenic TH17 cells. Nat Immunol 13: 991-999.
169. Letterio JJ, Geiser AG, Kulkarni AB, Roche NS, Sporn MB, Roberts AB. 1994. Maternal rescue of transforming growth factor-β1 null mice. Science 264: 1936-1938.
170. Leung JM, Davenport M, Wolff MJ, Wiens KE, Abidi WM, Poles MA, Cho I, Ullman T, Mayer L, Loke P. 2014. IL-22-producing CD4þ cells are depleted in actively inflamed colitis tissue. Mucosal Immunol 7: 124-133.
171. Li MO, Sanjabi S, Flavell RA. 2006a. Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and independent mechanisms. Immunity 25: 455-471.
172. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. 2006b. Transforming growth factor-β regulation of immune responses. Annu Rev Immunol 24: 99-146.
173. Li MO, Wan YY, Flavell RA. 2007. T cell-produced trans-forming growth factor-β1 controls T cell tolerance and regulates Th1-and Th17-cell differentiation. Immunity 26: 579-591.
174. Licona-Limón P, Henao-Mejia J, Temann Angela U, Gag-liani N, Licona-Limón I, Ishigame H, Hao L, Herbert DBroski R, Flavell Richard A. 2013. Th9 cells drive host immunity against gastrointestinal worm infection. Immunity 39: 744-757.
175. Lin YC, Stavnezer J. 1992. Regulation of transcription of the germ-line Iga constant region gene by an ATF element and by novel transforming growth factor-β1-responsive elements. J Immunol 149: 2914-2925.
176. Lin JT, Martin SL, Xia L, Gorham JD. 2005. TGF-β1 uses distinct mechanisms to inhibit IFN-g expression in CD4þ T cells at priming and at recall: Differential involvement of Stat4 and T-bet. J Immunol 174: 5950-5958.
177. Lin W, Weinberg EM, Tai AW, Peng LF, Brockman MA, Kim KA, Kim SS, Borges CB, Shao RX, Chung RT. 2008. HIV increases HCV replication in a TGF-β1-dependent manner. Gastroenterology 134: 803-811.
178. Liu Y, Zhang P, Li J, Kulkarni AB, Perruche S, Chen W. 2008. A critical function for TGF-β signaling in the development of natural CD4þCD25þFoxp3þ regulatory T cells. Nat Immunol 9: 632-640.
179. Liu Y, Islam EA, Jarvis GA, Gray-Owen SD, Russell MW. 2012. Neisseria gonorrhoeae selectively suppresses the development of Th1 and Th2 cells, and enhances Th17 cell responses, through TGF-β-dependent mechanisms. Mucosal Immunol 5: 320-331.
180. Loras B, Vetele F, El Malki A, Rollet J, Soufir JC, Benahmed M. 1999. Seminal transforming growth factor-β in normal and infertile men. Hum Reprod 14: 1534-1539.
181. Lotz M, Seth P. 1993. TGFβ and HIV infection. Ann NYAcad Sci 685: 501-511.
182. Lotz M, Clark-Lewis I, Ganu V. 1994. HIV-1 transactivator protein Tat induces proliferation and TGFβ expression in human articular chondrocytes. J Cell Biol 124: 365-371.
183. Lucas PJ, Kim SJ, Melby SJ, Gress RE. 2000. Disruption of T cell homeostasis in mice expressing a T-cell-specific dominant negative transforming growth factor β II receptor. J Exp Med 191: 1187-1196.
184. Lucas PJ, McNeil N, Hilgenfeld E, Choudhury B, Kim SJ, Eckhaus MA, Ried T, Gress RE. 2004. Transforming growth factor-β pathway serves as a primary tumor suppressor in CD8þ T cell tumorigenesis. Cancer Res 64: 6524-6529.
185. Lucas PJ, Kim SJ, Mackall CL, Telford WG, Chu YW, Hakim FT, Gress RE. 2006. Dysregulation of IL-15-mediated T-cell homeostasis in TGF-β dominant-negative receptor transgenic mice. Blood 108: 2789-2795.
186. Luttmann W, Franz P, Matthys H, Virchow JC Jr. 1998. Ef-fects of TGF-β on eosinophil chemotaxis. Scand J Immunol 47: 127-130.
187. Mackay LK, Rahimpour A, Ma JZ, Collins N, Stock AT, Hafon ML, Vega-Ramos J, Lauzurica P, Mueller SN, Stefanovic T, et al. 2013. The developmental pathway for CD103þCD8þ tissue-resident memory T cells of skin. Nat Immunol 14: 1294-1301.
188. Mackay LK, Wynne-Jones E, Freestone D, Pellicci DG, Mielke LA, Newman DM, Braun A, Masson F, Kallies A, Belz GT, et al. 2015. T-box transcription factors combine with the cytokines TGF-β and IL-15 to control tissue-resident memory T cell fate. Immunity 43: 1101-1111.
189. Maheshwari A, Kelly DR, Nicola T, Ambalavanan N, Jain SK, Murphy-Ullrich J, Athar M, Shimamura M, Bhandari V, Aprahamian C, et al. 2011. TGF-β2 suppresses macro-phage cytokine production and mucosal inflammatory responses in the developing intestine. Gastroenterology 140: 242-253.
190. Manel N, Unutmaz D, Littman DR. 2008. The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORgt. Nat Immunol 9: 641-649.
191. Marafini I, Zorzi F, Codazza S, Pallone F, Monteleone G. 2013. TGF-β signaling manipulation as potential therapy for IBD. Curr Drug Targets 14: 1400-1404.
192. Marcoe JP, Lim JR, Schaubert KL, Fodil-Cornu N, Matka M, McCubbrey AL, Farr AR, Vidal SM, Laouar Y. 2012. TGF-β is responsible for NK cell immaturity during ontogeny and increased susceptibility to infection during mouse infancy. Nat Immunol 13: 843-850.
193. Marie JC, Liggitt D, Rudensky AY. 2006. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-b receptor. Immunity 25: 441-454.
194. Marshall HD, Ray JP, Laidlaw BJ, Zhang N, Gawande D, Staron MM, Craft J, Kaech SM. 2015. The transforming growth factor β signaling pathway is critical for the formation of CD4 T follicular helper cells and isotype-switched antibody responses in the lung mucosa. eLife 4: e04851.
195. Martinez GJ, Zhang Z, Reynolds JM, Tanaka S, Chung Y, Liu T, Robertson E, Lin X, Feng XH, Dong C. 2010. Smad2 positively regulates the generation of Th17 cells. J Biol Chem 285: 29039-29043.
196. Maurya VK, Jha RK, Kumar V, Joshi A, Chadchan S, Mohan JJ, Laloraya M. 2013. Transforming growth factor-β1 (TGF-β1) liberation from its latent complex during embryo implantation and its regulation by estradiol in mouse. Biol Reprod 89: 84.
197. McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumen-schein W, McClanahan T, Cua DJ. 2007. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology. Nat Immunol 8: 1390-1397.
198. McGovern DP, Gardet A, Torkvist L, Goyette P, Essers J, Taylor KD, Neale BM, Ong RT, Lagace C, Li C, et al. 2010. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet 42: 332-337.
199. McKarns SC, Schwartz RH. 2005. Distinct effects of TGF-β1 on CD4þ and CD8þ T cell survival, division, and IL-2 production: A role for T cell intrinsic Smad3. J Immunol 174: 2071-2083.
200. McKarns SC, Schwartz RH, Kaminski NE. 2004. Smad3 is essential for TGF-β1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation. J Immunol 172: 4275-4284.
201. Mellor AL, Munn DH. 2004. IDO expression by dendritic cells: Tolerance and tryptophan catabolism. Nat Rev Immunol 4: 762-774.
202. Melton AC, Bailey-Bucktrout SL, Travis MA, Fife BT, Blue-stone JA, Sheppard D. 2010. Expression of avb8 integrin on dendritic cells regulates Th17 cell development and experimental autoimmune encephalomyelitis in mice. J Clin Invest 120: 4436-4444.
203. Miller HR, Wright SH, Knight PA, Thornton EM. 1999. A novel function for transforming growth factor-β1: Up-regulation of the expression and the IgE-independent extracellular release of a mucosal mast cell granule-specific β-chymase, mouse mast cell protease-1. Blood 93: 3473-3486.
204. Mokhtarian F, Shi Y, Shirazian D, Morgante L, Miller A, Grob D. 1994. Defective production of anti-inflammatory cytokine, TGF-β by T cell lines of patients with active multiple sclerosis. J Immunol 152: 6003-6010.
205. Molinero LL, Miller ML, Evaristo C, Alegre ML. 2011. High TCR stimuli prevent induced regulatory T cell differentiation in a NF-kB-dependent manner. J Immunol 186: 4609-4617.
206. Monteleone G, Kumberova A, Croft NM, McKenzie C, Steer HW, MacDonald TT. 2001. Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease. J Clin Invest 108: 601-609.
207. Monteleone G, Del Vecchio Blanco G, Monteleone I, Fina D, Caruso R, Gioia V, Ballerini S, Federici G, Bernardini S, Pallone F, et al. 2005. Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease. Gastroenterology 129: 1420-1429.
208. Monteleone G, Boirivant M, Pallone F, MacDonald TT. 2008. TGF-β1 and Smad7 in the regulation of IBD. Mucosal Immunol 1: S50-53.
209. Monteleone G, Fantini MC, Onali S, Zorzi F, Sancesario G, Bernardini S, Calabrese E, Viti F, Monteleone I, Biancone L, et al. 2012. Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn’s disease. Mol Ther 20: 870-876.
210. Moritani M, Yoshimoto K, Wong SF, Tanaka C, Yamaoka T, Sano T, Komagata Y, Miyazaki J, Kikutani H, Itakura M. 1998. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-β1. J Clin Invest 102: 499-506.
211. Munoz-Suano A, Hamilton AB, Betz AG. 2011. Gimme shelter: The immune system during pregnancy. Immunol Rev 241: 20-38.
212. Musso T, Espinoza-Delgado I, Pulkki K, Gusella GL, Longo DL, Varesio L. 1990. Transforming growth factor β down-regulates interleukin-1 (IL-1)-induced IL-6 production by human monocytes. Blood 76: 2466-2469.
213. Naiki Y, Michelsen KS, Zhang W, Chen S, Doherty TM, Arditi M. 2005. Transforming growth factor-β differentially inhibits MyD88-dependent, but not TRAM-and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling. J Biol Chem 280: 5491-5495.
214. Nandan D, Reiner NE. 1997. TGF-β attenuates the class II transactivator and reveals an accessory pathway of IFN-g action. J Immunol 158: 1095-1101.
215. Naviglio S, Arrigo S, Martelossi S, Villanacci V, Tommasini A, Loganes C, Fabretto A, Vignola S, Lonardi S, Ventura A. 2014. Severe inflammatory bowel disease associated with congenital alteration of transforming growth factor β signaling. J Crohns Colitis 8: 770-774.
216. Nelson BH, Martyak TP, Thompson LJ, Moon JJ, Wang T. 2003. Uncoupling of promitogenic and antiapoptotic functions of IL-2 by Smad-dependent TGF-β signaling. J Immunol 170: 5563-5570.
217. Nocera M, Chu TM. 1995. Characterization of latent trans-forming growth factor-β from human seminal plasma. Am J Reprod Immunol 33: 282-291.
218. Ocana-Morgner C, Wong KA, Lega F, Dotor J, Borras-Cuesta F, Rodriguez A. 2007. Role of TGF-β and PGE2 in T cell responses during Plasmodium yoelii infection. Eur J Im-munol 37: 1562-1574.
219. Oddy WH, Rosales F. 2010. A systematic review of the importance of milk TGF-β on immunological outcomes in the infant and young child. Pediatr Allergy Immunol 21: 47-59.
220. Ogawa J, Sasahara A, Yoshida T, Sira MM, Futatani T, Kane-gane H, Miyawaki T. 2004. Role of transforming growth factor-β in breast milk for initiation of IgA production in newborn infants. Early Hum Dev 77: 67-75.
221. Oh SA, Li MO. 2013. TGF-β: Guardian of T cell function. J Immunol 191: 3973-3979.
222. Ohtsuka K, Gray JD, Stimmler MM, Toro B, Horwitz DA. 1998. Decreased production of TGF-β by lymphocytes from patients with systemic lupus erythematosus. J Immunol 160: 2539-2545.
223. Ohtsuka K, Gray JD, Stimmler MM, Horwitz DA. 1999. The relationship between defects in lymphocyte production of transforming growth factor-β1 in systemic lupus erythematosus and disease activity or severity. Lupus 8: 90-94.
224. Olsson N, Piek E, ten Dijke P, Nilsson G. 2000. Human mast cell migration in response to members of the transforming growth factor-β family. J Leukoc Biol 67: 350-356.
225. Omer FM, Riley EM. 1998. Transforming growth factor β production is inversely correlated with severity of murine malaria infection. J Exp Med 188: 39-48.
226. Omer FM, de Souza JB, Corran PH, Sultan AA, Riley EM. 2003. Activation of transforming growth factor β by malaria parasite-derived metalloproteinases and a thrombo-spondin-like molecule. J Exp Med 198: 1817-1827.
227. Ouyang W, Beckett O, Ma Q, Li MO. 2010. Transforming growth factor-β signaling curbs thymic negative selection promoting regulatory T cell development. Immunity 32: 642-653.
228. Ouyang W, Oh SA, Ma Q, Bivona MR, Zhu J, Li MO. 2013. TGF-β signaling promotes CD8þ T cell development and low-affinity CD4þ T cell homeostasis by regulation of interleukin-7 receptor a expression. Immunity 39: 335-346.
229. Owyang AM, Zaph C, Wilson EH, Guild KJ, McClanahan T, Miller HR, Cua DJ, Goldschmidt M, Hunter CA, Kastelein RA, et al. 2006. Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflamma-tion in the gastrointestinal tract. J Exp Med 203: 843-849.
230. Paidassi H, Acharya M, Zhang A, Mukhopadhyay S, Kwon M, Chow C, Stuart LM, Savill J, Lacy-Hulbert A. 2011. Preferential expression of integrin avb8 promotes generation of regulatory T cells by mouse CD103þ dendritic cells. Gastroenterology 141: 1813-1820.
231. Pallotta MT, Orabona C, Volpi C, Vacca C, Belladonna ML, Bianchi R, Servillo G, Brunacci C, Calvitti M, Bicciato S, et al. 2011. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat Immunol 12: 870-878.
232. Pardali E, Xie XQ, Tsapogas P, Itoh S, Arvanitidis K, Heldin CH, ten Dijke P, Grundstrom T, Sideras P. 2000. Smad and AML proteins synergistically confer transforming growth factor β1 responsiveness to human germ-line IgA genes. J Biol Chem 275: 3552-3560.
233. Park SR, Lee JH, Kim PH. 2001. Smad3 and Smad4 mediate transforming growth factor-β1-induced IgA expression in murine B lymphocytes. Eur J Immunol 31: 1706-1715.
234. Park JH, Yu Q, Erman B, Appelbaum JS, Montoya-Durango D, Grimes HL, Singer A. 2004. Suppression of IL7Ra transcription by IL-7 and other prosurvival cytokines: A novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 21: 289-302.
235. Park JH, Adoro S, Guinter T, Erman B, Alag AS, Catalfamo M, Kimura MY, Cui Y, Lucas PJ, Gress RE, et al. 2010. Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells. Nat Immunol 11: 257-264.
236. Park YP, Choi SC, Kiesler P, Gil-Krzewska A, Borrego F, Weck J, Krzewski K, Coligan JE. 2011. Complex regulation of human NKG2D-DAP10 cell surface expression: Opposing roles of the gc cytokines and TGF-β1. Blood 118: 3019-3027.
237. Penttila IA. 2010. Milk-derived transforming growth factor-β and the infant immune response. J Pediatr 156: S21-S25.
238. Penttila IA, van Spriel AB, Zhang MF, Xian CJ, Steeb CB, Cummins AG, Zola H, Read LC. 1998. Transforming growth factor-β levels in maternal milk and expression in postnatal rat duodenum and ileum. Pediatr Res 44: 524-531.
239. Pereira FA, Pinheiro da Silva NN, Rodart IF, Carmo TM, Lemaire DC, Reis MG. 2008. Association of TGF-β1 codon 25 (G915C) polymorphism with hepatitis C virus infection. J Med Virol 80: 58-64.
240. Petit-Koskas E, Genot E, Lawrence D, Kolb JP. 1988. Inhibi-tion of the proliferative response of human B lymphocytes to B cell growth factor by transforming growth factor-β. Eur J Immunol 18: 111-116.
241. Pion M, Jaramillo-Ruiz D, Martinez A, Munoz-Fernandez MA, Correa-Rocha R. 2013. HIV infection of human regulatory T cells downregulates Foxp3 expression by increasing DNMT3b levels and DNA methylation in the FOXP3 gene. AIDS 27: 2019-2029.
242. Piskurich JF, Wang Y, Linhoff MW, White LC, Ting JP. 1998. Identification of distinct regions of 50 flanking DNA that mediate constitutive, IFN-g, STAT1, and TGF-β-regulated expression of the class II transactivator gene. J Immunol 160: 233-240.
243. Planchon SM, Martins CA, Guerrant RL, Roche JK. 1994. Regulation of intestinal epithelial barrier function by TGF-β1. Evidence for its role in abrogating the effect of a T cell cytokine. J Immunol 153:5730-5739.
244. Planchon S, Fiocchi C, Takafuji V, Roche JK. 1999. Transforming growth factor-β1 preserves epithelial barrier function: Identification of receptors, biochemical inter-mediates, and cytokine antagonists. J Cell Physiol 181: 55-66.
245. Ploquin MJ, Desoutter JF, Santos PR, Pandrea I, Diop OM, Hosmalin A, Butor C, Barre-Sinoussi F, Muller-Trutwin MC. 2006. Distinct expression profiles of TGF-β1 signaling mediators in pathogenic SIVmac and non-pathogenic SIVagm infections. Retrovirology 3: 37.
246. Pobezinsky LA, Angelov GS, Tai X, Jeurling S, Van Laethem F, Feigenbaum L, Park JH, Singer A. 2012. Clonal deletion and the fate of autoreactive thymocytes that survive negative selection. Nat Immunol 13: 569-578.
247. Polli V, Bulletti C, Galassi A, Borini A, Ciotti PM, Seracchioli R, Alfieri S, Flamigni C. 1996. Transforming growth factor-β1 in the human endometrium. Gynecol Endocrinol 10: 297-302.
248. PrabhuDas M, Adkins B, Gans H, King C, Levy O, Ramilo O, Siegrist CA. 2011. Challenges in infant immunity: Implications for responses to infection and vaccines. Nat Immunol 12: 189-194.
249. Prokesova L, Lodinova-Zadnikova R, Zizka J, Kocourkova I, Novotna O, Petraskova P, Sterzl I. 2006. Cytokine levels in healthy and allergic mothers and their children during the first year of life. Pediatr Allergy Immunol 17: 175-183.
250. Racke MK, Dhib-Jalbut S, Cannella B, Albert PS, Raine CS, McFarlin DE. 1991. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β1. J Immunol 146: 3012-3017.
251. Ramalingam R, Larmonier CB, Thurston RD, Midura-Kiela MT, Zheng SG, Ghishan FK, Kiela PR. 2012. Dendritic cell-specific disruption of TGF-β receptor II leads to altered regulatory T cell phenotype and spontaneous multiorgan autoimmunity. J Immunol 189: 3878-3893.
252. Rani R, Smulian AG, Greaves DR, Hogan SP, Herbert DR. 2011. TGF-β limits IL-33 production and promotes the resolution of colitis through regulation of macrophage function. Eur J Immunol 41: 2000-2009.
253. Rautava S, Lu L, Nanthakumar NN, Dubert-Ferrandon A, Walker WA. 2012. TGF-β2 induces maturation of immature human intestinal epithelial cells and inhibits inflammatory cytokine responses induced via the NF-kB path-way. J Pediatr Gastroenterol Nutr 54: 630-638.
254. Raz E, Dudler J, Lotz M, Baird SM, Berry CC, Eisenberg RA, Carson DA. 1995. Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene de-livery. Lupus 4: 286-292.
255. Reibman J, Meixler S, Lee TC, Gold LI, Cronstein BN, Haines KA, Kolasinski SL, Weissmann G. 1991. Transforming growth factor β1, a potent chemoattractant for human neutrophils, bypasses classic signal-transduction pathways. Proc Natl Acad Sci 88: 6805-6809.
256. Reinhold D, Wrenger S, Kahne T, Ansorge S. 1999. HIV-1 Tat: Immunosuppression via TGF-β1 induction. Immunol Today 20: 384-385.
257. Reis BS, Rogoz A, Costa-Pinto FA, Taniuchi I, Mucida D. 2013. Mutual expression of the transcription factors Runx3 and ThPOK regulates intestinal CD4þ T cell immunity. Nat Immunol 14: 271-280.
258. Robertson SA. 2005. Seminal plasma and male factor signal-ling in the female reproductive tract. Cell Tissue Res 322: 43-52.
259. Robertson IB, Rifkin DB. 2016. Regulation of the bioavail-ability of TGF-β and TGF-β-related proteins. Cold Spring Harb Perspect Biol 8: a021907.
260. Robertson SA, Ingman WV, O’Leary S, Sharkey DJ, Tre-mellen KP. 2002. Transforming growth factor β-A mediator of immune deviation in seminal plasma. J Reprod Immunol 57: 109-128.
261. Robertson SA, Guerin LR, Bromfield JJ, Branson KM, Ahlstrom AC, Care AS. 2009a. Seminal fluid drives expansion of the CD4þCD25þ T regulatory cell pool and induces tolerance to paternal alloantigens in mice. Biol Reprod 80: 1036-1045.
262. Robertson SA, Guerin LR, Moldenhauer LM, Hayball JD. 2009b. Activating T regulatory cells for tolerance in early pregnancy-The contribution of seminal fluid. J Reprod Immunol 83: 109-116.
263. Robertson SA, Prins JR, Sharkey DJ, Moldenhauer LM. 2013. Seminal fluid and the generation of regulatory T cells for embryo implantation. Am J Reprod Immunol 69: 315-330.
264. Robinson RT, Gorham JD. 2007. TGF-β1 regulates antigen-specific CD4þ T cell responses in the periphery. J Immunol 179: 71-79.
265. Romani N, Clausen BE, Stoitzner P. 2010. Langerhans cells and more: Langerin-expressing dendritic cell subsets in the skin. Immunol Rev 234: 120-141.
266. Rosbottom A, Scudamore CL, von der Mark H, Thornton EM, Wright SH, Miller HR. 2002. TGF-β1 regulates adhesion of mucosal mast cell homologues to laminin-1 through expression of integrin a7. J Immunol 169: 5689-5695.
267. Rothlin CV, Ghosh S, Zuniga EI, Oldstone MB, Lemke G. 2007. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131: 1124-1136.
268. Rowan AG, Fletcher JM, Ryan EJ, Moran B, Hegarty JE, O’Farrelly C, Mills KH. 2008. Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-β. J Immunol 181: 4485-4494.
269. Rowe JH, Ertelt JM, Xin L, Way SS. 2012. Pregnancy im-prints regulatory memory that sustains anergy to fetal antigen. Nature 490: 102-106.
270. Ruegemer JJ, Ho SN, Augustine JA, Schlager JW, Bell MP, McKean DJ, Abraham RT. 1990. Regulatory effects of transforming growth factor-β on IL-2-and IL-4-depen-dent T cell-cycle progression. J Immunol 144: 1767-1776.
271. Rumsaeng V, Vliagoftis H, Oh CK, Metcalfe DD. 1997. Lym-photactin gene expression in mast cells following Fc1 receptor I aggregation: Modulation by TGF-β, IL-4, dexamethasone, and cyclosporin A. J Immunol 158: 1353-1360.
272. Rutz S, Noubade R, Eidenschenk C, Ota N, Zeng W, Zheng Y, Hackney J, Ding J, Singh H, Ouyang W. 2011. Transcription factor c-Maf mediates the TGF-β-dependent suppression of IL-22 production in TH17 cells. Nat Immunol 12: 1238-1245.
273. Saarinen KM, Juntunen-Backman K, Jarvenpaa AL, Kle-metti P, Kuitunen P, Lope L, Renlund M, Siivola M, Vaarala O, Savilahti E. 2000. Breast-feeding and the development of cows’ milk protein allergy. Adv Exp Med Biol 478: 121-130.
274. Saito S, Yoshida M, Ichijo M, Ishizaka S, Tsujii T. 1993. Transforming growth factor-β (TGF-β) in human milk. Clin Exp Immunol 94: 220-224.
275. Salehi S, Bankoti R, Benevides L, Willen J, Couse M, Silva JS, Dhall D, Meffre E, Targan S, Martins GA. 2012. B lymphocyte-induced maturation protein-1 contributes to intestinal mucosa homeostasis by limiting the number of IL-17-producing CD4þ T cells. J Immunol 189: 5682-5693.
276. Samstein RM, Josefowicz SZ, Arvey A, Treuting PM, Ruden-sky AY. 2012. Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell 150: 29-38.
277. Sanjabi S, Mosaheb MM, Flavell RA. 2009. Opposing effects of TGF-β and IL-15 cytokines control the number of short-lived effector CD8þ T cells. Immunity 31: 131-144.
278. Sawaya BE, Thatikunta P, Denisova L, Brady J, Khalili K, Amini S. 1998. Regulation of TNFa and TGFβ-1 gene transcription by HIV-1 Tat in CNS cells. J Neuroimmunol 87: 33-42.
279. Schenkel JM, Masopust D. 2014. Tissue-resident memory T cells. Immunity 41: 886-897.
280. Schlenner SM, Weigmann B, Ruan Q, Chen Y, von Boehmer H. 2012. Smad3 binding to the foxp3 enhancer is dispensable for the development of regulatory T cells with the exception of the gut. J Exp Med 209: 1529-1535.
281. Schmitt N, Liu Y, Bentebibel SE, Munagala I, Bourdery L, Venuprasad K, Banchereau J, Ueno H. 2014. The cytokine TGF-β co-opts signaling via STAT3-STAT4 to promote the differentiation of human TFH cells. Nat Immunol 15: 856-865.
282. Scholzen A, Mittag D, Rogerson SJ, Cooke BM, Plebanski M. 2009. Plasmodium falciparum-mediated induction of human CD25hiFoxp3hi CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFβ. PLoS Path 5: e1000543.
283. Schon MP, Arya A, Murphy EA, Adams CM, Strauch UG, Agace WW, Marsal J, Donohue JP, Her H, Beier DR, et al. 1999. Mucosal T lymphocyte numbers are selectively reduced in integrin aE (CD103)-deficient mice. J Immunol 162: 6641-6649.
284. Schramm C, Kriegsmann J, Protschka M, Huber S, Hansen T, Schmitt E, Galle PR, Blessing M. 2004. Susceptibility to collagen-induced arthritis is modulated by TGFβ responsiveness of T cells. Arthritis Res Ther 6: R114-R119.
285. Schultz-Cherry S, Hinshaw VS. 1996. Influenza virus neuraminidase activates latent transforming growth factor β. J Virol 70: 8624-8629.
286. Selvaraj RK, Geiger TL. 2007. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-β. J Immunol 179: 11.
287. Sharif MN, Sosic D, Rothlin CV, Kelly E, Lemke G, Olson EN, Ivashkiv LB. 2006. Twist mediates suppression of inflammation by type I IFNs and Axl. J Exp Med 203: 1891-1901.
288. Sharma M, Kaveri SV, Bayry J. 2013. Th17 cells, pathogenic or not? TGF-β3 imposes the embargo. Cell Mol Immunol 10: 101-102.
289. Shen R, Meng G, Ochsenbauer C, Clapham PR, Grams J, Novak L, Kappes JC, Smythies LE, Smith PD. 2011. Stromal down-regulation of macrophage CD4/CCR5 expression and NF-kB activation mediates HIV-1 non-permissiveness in intestinal macrophages. PLoS Path 7: e1002060.
290. Sheridan BS, Pham QM, Lee YT, Cauley LS, Puddington L, Lefrancois L. 2014. Oral infection drives a distinct population of intestinal resident memory CD8þ T cells with enhanced protective function. Immunity 40: 747-757.
291. Shevach EM, Thornton AM. 2014. tTregs, pTregs, and iTregs: Similarities and differences. Immunol Rev 259: 88-102.
292. Shi MJ, Stavnezer J. 1998. CBFa3 (AML2) is induced by TGF-β1 to bind and activate the mouse germline Iga promoter. J Immunol 161: 6751-6760.
293. Shockett P, Stavnezer J. 1991. Effect of cytokines on switching to IgA and a germline transcripts in the B lymphoma I.29m. Transforming growth factor-β activates transcription of the unrearranged Ca gene. J Immunol 147: 4374-4383.
294. Sillett HK, Cruickshank SM, Southgate J, Trejdosiewicz LK. 2001. Transforming growth factor-β promotes “death by neglect” in post-activated human T cells. Immunology 102: 310-316.
295. Silva JS, Twardzik DR, Reed SG. 1991. Regulation of Trypa-nosoma cruzi infections in vitro and in vivo by transforming growth factor β (TGF-β). J Exp Med 174: 539-545.
296. Singh NJ, Bando JK, Schwartz RH. 2012. Subsets of nonclonal neighboring CD4þ T cells specifically regulate the frequency of individual antigen-reactive T cells. Immunity 37: 735-746.
297. Skon CN, Lee JY, Anderson KG, Masopust D, Hogquist KA, Jameson SC. 2013. Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8þ T cells. Nat Immunol 14: 1285-1293.
298. Sledzinska A, Hemmers S, Mair F, Gorka O, Ruland J, Fairbairn L, Nissler A, Muller W, Waisman A, Becher B, et al. 2013. TGF-β signalling is required for CD4þ T cell homeostasis but dispensable for regulatory T cell function. PLoS Biol 11: e1001674.
299. Smith WB, Noack L, Khew-Goodall Y, Isenmann S, Vadas MA, Gamble JR. 1996. Transforming growth factor-β1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium. J Immunol 157: 360-368.
300. Smith K, Seddon B, Purbhoo MA, Zamoyska R, Fisher AG, Merkenschlager M. 2001. Sensory adaptation in naïve peripheral CD4 T cells. J Exp Med 194: 1253-1261.
301. Smythies LE, Sellers M, Clements RH, Mosteller-Barnum M, Meng G, Benjamin WH, Orenstein JM, Smith PD. 2005. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacter-iocidal activity. J Clin Invest 115: 66-75.
302. Smythies LE, Maheshwari A, Clements R, Eckhoff D, Novak L, Vu HL, Mosteller-Barnum LM, Sellers M, Smith PD. 2006. Mucosal IL-8 and TGF-β recruit blood monocytes: Evidence for cross-talk between the lamina propria stroma and myeloid cells. J Leukoc Biol 80: 492-499.
303. Sonoda E, Matsumoto R, Hitoshi Y, Ishii T, Sugimoto M, Araki S, Tominaga A, Yamaguchi N, Takatsu K. 1989. Transforming growth factor β induces IgA production and acts additively with interleukin 5 for IgA production. J Exp Med 170: 1415-1420.
304. Stevceva L, Yoon V, Carville A, Pacheco B, Santosuosso M, Korioth-Schmitz B, Mansfield K, Poznansky MC. 2008. The efficacy of T cell-mediated immune responses is reduced by the envelope protein of the chimeric HIV-1/ SIV-KB9 virus in vivo. J Immunol 181: 5510-5521.
305. Stockis J, Colau D, Coulie PG, Lucas S. 2009. Membrane protein GARP is a receptor for latent TGF-β on the sur-face of activated human Treg. Eur J Immunol 39: 3315-3322.
306. Strainic MG, Shevach EM, An F, Lin F, Medof ME. 2012. Absence of signaling into CD4þ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3þ regulatory T cells. Nat Immunol 14: 162-171.
307. Stritesky GL, Jameson SC, Hogquist KA. 2012. Selection of self-reactive T cells in the thymus. Annu Rev Immunol 30: 95-114.
308. Strobl H, Riedl E, Scheinecker C, Bello-Fernandez C, Pickl WF, Rappersberger K, Majdic O, Knapp W. 1996. TGF-β1 promotes in vitro development of dendritic cells from CD34þ hemopoietic progenitors. J Immunol 157: 1499-1507.
309. Su HC, Leite-Morris KA, Braun L, Biron CA. 1991. A role for transforming growth factor-β1 in regulating natural killer cell and T lymphocyte proliferative responses during acute infection with lymphocytic choriomeningitis virus. J Immunol 147: 2717-2727.
310. Su HC, Ishikawa R, Biron CA. 1993. Transforming growth factor-β expression and natural killer cell responses during virus infection of normal, nude, and SCID mice. J Immunol 151: 4874-4890.
311. Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR, Belkaid Y. 2007. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 204: 1775-1785.
312. Sun C, Fu B, Gao Y, Liao X, Sun R, Tian Z, Wei H. 2012. TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/ SAP expression on human NK cells contributes to HBV persistence. PLoS Pathog 8: e1002594.
313. Sung JL, Lin JT, Gorham JD. 2003. CD28 co-stimulation regulates the effect of transforming growth factor-β1 on the proliferation of naive CD4þ T cells. Int Immunophar-macol 3: 233-245.
314. Suzuki R, Nakao A, Kanamaru Y, Okumura K, Ogawa H, Ra C. 2002. Localization of intestinal intraepithelial T lymphocytes involves regulation of aEb7 expression by transforming growth factor-β. Int Immunol 14: 339-345.
315. Takahashi T, Eitzman B, Bossert NL, Walmer D, Sparrow K, Flanders KC, McLachlan J, Nelson KG. 1994. Transforming growth factors β1, β2, and β3 messenger RNA and protein expression in mouse uterus and vagina during estrogen-induced growth: A comparison to other estro-gen-regulated genes. Cell Growth Differ 5: 919-935.
316. Takimoto T, Wakabayashi Y, Sekiya T, Inoue N, Morita R, Ichiyama K, Takahashi R, Asakawa M, Muto G, Mori T, et al. 2010. Smad2 and Smad3 are redundantly essential for the TGF-β-mediated regulation of regulatory T plasticity and Th1 development. J Immunol 185: 842-855.
317. Tamiya T, Ichiyama K, Kotani H, Fukaya T, Sekiya T, Shichita T, Honma K, Yui K, Matsuyama T, Nakao T, et al. 2013. Smad2/3 and IRF4 play a cooperative role in IL-9-pro-ducing T cell induction. J Immunol 191: 2360-2371.
318. Tas SW, Vervoordeldonk MJ, Hajji N, Schuitemaker JH, van der Sluijs KF, May MJ, Ghosh S, Kapsenberg ML, Tak PP, de Jong EC. 2007. Noncanonical NF-kB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation. Blood 110: 1540-1549.
319. Thorbecke GJ, Shah R, Leu CH, Kuruvilla AP, Hardison AM, Palladino MA. 1992. Involvement of endogenous tumor necrosis factor a and transforming growth factor β during induction of collagen type II arthritis in mice. Proc Natl Acad Sci 89: 7375-7379.
320. Tinoco R, Alcalde V, Yang Y, Sauer K, Zuniga EI. 2009. Cell-intrinsic transforming growth factor-β signaling mediates virus-specific CD8þ T cell deletion and viral persistence in vivo. Immunity 31: 145-157.
321. Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, Tone M. 2008. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol 9: 194-202.
322. Torchinsky MB, Garaude J, Martin AP, Blander JM. 2009. Innate immune recognition of infected apoptotic cells directs TH17 cell differentiation. Nature 458: 78-82.
323. Tran DQ, Andersson J, Wang R, Ramsey H, Unutmaz D, Shevach EM. 2009. GARP (LRRC32) is essential for the surface expression of latent TGF-β on platelets and activated FOXP3þ regulatory T cells. Proc Natl Acad Sci 106: 13445-13450.
324. Travis MA, Sheppard D. 2014. TGF-β activation and function in immunity. Annu Rev Immunol 32: 51-82.
325. Travis MA, Reizis B, Melton AC, Masteller E, Tang Q, Proctor JM, Wang Y, Bernstein X, Huang X, Reichardt LF, et al. 2007. Loss of integrin avb8 on dendritic cells causes autoimmunity and colitis in mice. Nature 449: 361-365.
326. Turner M, Chantry D, Feldmann M. 1990. Transforming growth factor β induces the production of interleukin 6 by human peripheral blood mononuclear cells. Cytokine 2: 211-216.
327. Tzachanis D, Freeman GJ, Hirano N, van Puijenbroek AA, Delfs MW, Berezovskaya A, Nadler LM, Boussiotis VA. 2001. Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells. Nat Immunol 2: 1174-1182.
328. van Vlasselaer P, Punnonen J, de Vries JE. 1992. Transform-ing growth factor-β directs IgA switching in human B cells. J Immunol 148: 2062-2067.
329. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stock-inger B. 2006a. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189.
330. Veldhoen M, Hocking RJ, Flavell RA, Stockinger B. 2006b. Signals mediated by transforming growth factor-β initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat Immunol 7: 1151-1156.
331. Verhasselt V. 2010. Neonatal tolerance under breastfeeding influence. Curr Opin Immunol 22: 623-630.
332. Verhasselt V, Milcent V, Cazareth J, Kanda A, Fleury S, Dombrowicz D, Glaichenhaus N, Julia V. 2008. Breast milk-mediated transfer of an antigen induces tolerance and protection from allergic asthma. Nat Med 14: 170-175.
333. Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, Roberts AB, Sporn MB. 1987. Transforming growth factor type b induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci 84: 5788-5792.
334. Wahl SM, Allen JB, McCartney-Francis N, Morganti-Koss-mann MC, Kossmann T, Ellingsworth L, Mai UE, Mergenhagen SE, Orenstein JM. 1991. Macrophage-and astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J Exp Med 173: 981-991.
335. Wahl SM, Allen JB, Costa GL, Wong HL, Dasch JR. 1993a. Reversal of acute and chronic synovial inflammation by anti-transforming growth factor β. J Exp Med 177: 225-230.
336. Wahl SM, Allen JB, Weeks BS, Wong HL, Klotman PE. 1993b. Transforming growth factor β enhances integrin expression and type IV collagenase secretion in human monocytes. Proc Natl Acad Sci 90: 4577-4581.
337. Walther M, Tongren JE, Andrews L, Korbel D, King E, Fletcher H, Andersen RF, Bejon P, Thompson F, Dunachie SJ, et al. 2005. Upregulation of TGF-β, FOXP3, and CD4þCD25þ regulatory T cells correlates with more rap-id parasite growth in human malaria infection. Immunity 23: 287-296.
338. Wang J, Guan E, Roderiquez G, Norcross MA. 2001. Syner-gistic induction of apoptosis in primary CD4þ T cells by macrophage-tropic HIV-1 and TGF-β1. J Immunol 167: 3360-3366.
339. Wang R, Kozhaya L, Mercer F, Khaitan A, Fujii H, Unutmaz D. 2009. Expression of GARP selectively identifies activated human FOXP3þ regulatory T cells. Proc Natl Acad Sci 106: 13439-13444.
340. Wang R, Zhu J, Dong X, Shi M, Lu C, Springer TA. 2012. GARP regulates the bioavailability and activation of TGFβ. Mol Biol Cell 23: 1129-1139.
341. Wang A, Pan D, Lee YH, Martinez GJ, Feng XH, Dong C. 2013. Cutting edge: Smad2 and Smad4 regulate TGF-β-mediated Il9 gene expression via EZH2 displacement. J Immunol 191: 4908-4912.
342. Warner GL, Ludlow JW, Nelson DA, Gaur A, Scott DW. 1992. Anti-immunoglobulin treatment of murine B-cell lymphomas induces active transforming growth factor β but pRB hypophosphorylation is transforming growth factor β independent. Cell Growth Differ 3: 175-181.
343. Wei J, Duramad O, Perng OA, Reiner SL, Liu YJ, Qin FX. 2007. Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3þ regulatory T cells. Proc Natl Acad Sci 104: 18169-18174.
344. Weiner HL. 2001. Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells. Immunol Rev 182: 207-214.
345. Wiercinska-Drapalo A, Flisiak R, Jaroszewicz J, Prokopo-wicz D. 2004. Increased plasma transforming growth factor-β1 is associated with disease progression in HIV-1-infected patients. Viral Immunol 17: 109-113.
346. Windhagen A, Scholz C, Hollsberg P, Fukaura H, Sette A, Hafler DA. 1995. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 2: 373-380.
347. Wira CR, Rossoll RM. 2003. Oestradiol regulation of antigen presentation by uterine stromal cells: role of transforming growth factor-β production by epithelial cells in mediating antigen-presenting cell function. Immunology 109: 398-406.
348. Wira CR, Roche MA, Rossoll RM. 2002. Antigen presentation by vaginal cells: Role of TGFβ as a mediator of estradiol inhibition of antigen presentation. Endocrinology 143: 2872-2879.
349. Wolfraim LA, Walz TM, James Z, Fernandez T, Letterio JJ. 2004. p21Cip1 and p27Kip1 act in synergy to alter the sensitivity of naive T cells to TGF-β-mediated G1 arrest through modulation of IL-2 responsiveness. J Immunol 173: 3093-3102.
350. Worthington JJ, Czajkowska BI, Melton AC, Travis MA. 2011. Intestinal dendritic cells specialize to activate transforming growth factor-β and induce Foxp3þ regulatory T cells via integrin avb8. Gastroenterology 141: 1802-1812.
351. Xiao X, Balasubramanian S, Liu W, Chu X, Wang H, Taparowsky EJ, Fu YX, Choi Y, Walsh MC, Li XC. 2012. OX40 signaling favors the induction of TH9 cells and airway inflammation. Nat Immunol 13: 981-990.
352. Xu L, Kitani A, Stuelten C, McGrady G, Fuss I, Strober W. 2010. Positive and negative transcriptional regulation of the Foxp3 gene is mediated by access and binding of the Smad3 protein to enhancer I. Immunity 33: 313-325.
353. Yamagiwa S, Gray JD, Hashimoto S, Horwitz DA. 2001. A role for TGF-β in the generation and expansion of CD4þCD25þ regulatory T cells from human peripheral blood. J Immunol 166: 7282-7289.
354. Yamaguchi Y, Tsumura H, Miwa M, Inaba K. 1997. Contrasting effects of TGF-β1 and TNF-a on the development of dendritic cells from progenitors in mouse bone marrow. Stem Cells 15: 144-153.
355. Yang X, Letterio JJ, Lechleider RJ, Chen L, Hayman R, Gu H, Roberts AB, Deng C. 1999. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β. EMBO J 18: 1280-1291.
356. Yang L, Anderson DE, Baecher-Allan C, Hastings WD, Bet-telli E, Oukka M, Kuchroo VK, Hafler DA. 2008. IL-21 and TGF-β are required for differentiation of human TH17 cells. Nature 454: 350-352.
357. Yu J, Wei M, Becknell B, Trotta R, Liu S, Boyd Z, Jaung MS, Blaser BW, Sun J, Benson DM Jr, et al. 2006. Pro-and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-g production by human natural killer cells. Immunity 24: 575-590.
358. Zahner SP, Kel JM, Martina CA, Brouwers-Haspels I, van Roon MA, Clausen BE. 2011. Conditional deletion of TGF-βR1 using Langerin-Cre mice results in Langerhans cell deficiency and reduced contact hypersensitivity. J Immunol 187: 5069-5076.
359. Zauli G, Davis BR, Re MC, Visani G, Furlini G, La Placa M. 1992. tat protein stimulates production of transforming rowth factor-β1 by marrow macrophages: A potential mechanism for human immunodeficiency virus-1-in-duced hematopoietic suppression. Blood 80: 3036-3043.
360. Zenclussen AC. 2006. Regulatory T cells in pregnancy. Springer Semin Immunopathol 28: 31-39.
361. Zeng M, Smith AJ, Wietgrefe SW, Southern PJ, Schacker TW, Reilly CS, Estes JD, Burton GF, Silvestri G, Lifson JD, et al. 2011. Cumulative mechanisms of lymphoid tissue fibro-sis and T cell depletion in HIV-1 and SIV infections. J Clin Invest 121: 998-1008.
362. Zhang N, Bevan MJ. 2012. TGF-β signaling to T cells inhibits autoimmunity during lymphopenia-driven proliferation. Nat Immunol 13: 667-673.
363. Zhang N, Bevan MJ. 2013. Transforming growth factor-β signaling controls the formation and maintenance of gut-resident memory T cells by regulating migration and retention. Immunity 39: 687-696.
364. Zhang Y, Derynck R. 2000. Transcriptional regulation of the transforming growth factor-β-inducible mouse germ line Iga constant region gene by functional cooperation of Smad, CREB, and AML family members. J Biol Chem 275: 16979-16985.
365. Zhang MF, Zola H, Read LC, Penttila IA. 1999a. Localization of transforming growth factor-β receptor types I, II, and III in the postnatal rat small intestine. Pediatr Res 46: 657-665.
366. Zhang Y, Zhang YY, Ogata M, Chen P, Harada A, Hashimoto S, Matsushima K. 1999b. Transforming growth factor-β1 polarizes murine hematopoietic progenitor cells to generate Langerhans cell-like dendritic cells through a monocyte/macrophage differentiation pathway. Blood 93: 1208-1220.
367. Zhao Y, Chegini N, Flanders KC. 1994. Human fallopian tube expresses transforming growth factor (TGFβ) isoforms, TGFβ type I-III receptor messenger ribonucleic acid and protein, and contains [125I]TGFβ-binding sites. J Clin Endocrinol Metab 79: 1177-1184.
368. Zhao F, Hoechst B, Gamrekelashvili J, Ormandy LA, Voigt-lander T, Wedemeyer H, Ylaya K, Wang XW, Hewitt SM, Manns MP, et al. 2012. Human CCR4þ CCR6þ Th17 cells suppress autologous CD8þ T cell responses. J Immunol 188: 6055-6062.
369. Zheng Y, Josefowicz S, Chaudhry A, Peng XP, Forbush K, Rudensky AY. 2010. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463: 808-812.
370. Zhou P, Miller G, Seder RA. 1998. Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-a plays a critical role in maintaining secondary immunity in the absence of IFN-g. J Immunol 160: 1359-1368.
371. Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, Levy DE, Leonard WJ, Littman DR. 2007. IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8: 967-974.
372. Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY, et al. 2008. TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORgt function. Nature 453: 236-240.
373. Zhu J, Davidson TS, Wei G, Jankovic D, Cui K, Schones DE, Guo L, Zhao K, Shevach EM, Paul WE. 2009. Down-regulation of Gfi-1 expression by TGF-β is important for differentiation of Th17 and CD103þ inducible regulatory T cells. J Exp Med 206: 329-341.